BIOBIJOU
Expanding Global Sales network
China has been the largest market for Biobijou, and we’re expanding our business to other countries.
As a result, a sales network of 11 countries’ markets have been secured so far.
Strengthen competitiveness our products by adding various types of functional ingredients,
KFDA and CE marking will be completed by 2023.
Since 2018
Since 2018, Biobijou started overseas exports mainly in China and Hong Kong including other Northeast Asian countries.
Expanding sales network in 11 more countries including the Middle East, South America, and Europe.
Biobijou exports to
Iraq, Dominican Republic, Turkey, China, Vietnam, Hong Kong, Russia, Malaysia,
United Kingdom, CIS, Colombia
Biobijou exports to – in progress
Brazil, Iran, Morocco, Israel, United Arab Emirates, Azerbaijan, Portugal, Thailand,
Singapore, Mexico, Philippines
-
VietnamAesthetic industry in Vietnam has been rising continuously at an average of 12.7 %p annually between 2014 and 2019.
The total amount of botulinum toxin and dermal fillers Vietnam imported from Korea is USD 20 million in 2016 in official statistics.
-
ThailandThe total number of cosmetic surgeries in Thailand was approximately 140,000 cases, ranked the 10th in the world in 2018.
In 35,000 non-surgical procedures, botulinum toxin injection accounted for 58.7%. In the case of HA filler injection, accounted for 27.1%.
Southeast Asian Countries
-
BrazilA country with a population of 210 million with a high interest in cosmetic surgery
World's the 3rd largest HA filler consuming country
-
Mexico24 brands of HA fillers are registered in Mexico, ranked the 6th in the world.
Steep growth more than 10%p annually.
Latin America and the Caribbean
-
RussiaThe amount of cosmetic surgery industry in Russia is 12 billion rubles
Imports of botulinum toxin/filler, etc. from Korea: USD 18 million
-
UkraineThe Ukraine aesthetic market has scored 87% growth rate from 2018 to 2020.
Ukraine is a key location for global aesthetic companies to enter the former CIS countries.
CIS
Biobijou, a leading company in Chinese market
China, the best prospective market
The growth of Chinese market
China has emerged as the world’s second largest medical aesthetic country after the U.S.A.
The fastest-growing country in the medical aesthetic market in the world.
The size of dermal filler market in China is expected to grow
from USD 0.73 billion in 2022 to USD 1.49 billion in 2023.
Strengths of Biobijou
As we manufacture our own dermal fillers, more than 600,000
of our products have been sold in Chinese market.
Company board members have extensive experience in marketing and distribution of cosmetics
and dermal fillers in China.
Resourceful key doctor network in China
Presentation and demonstration of our company's products for the invitied key doctors to Korea
Expanding market share with resourceful key doctor network in Chinese market
